Compare NPCE & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | MOV |
|---|---|---|
| Founded | 1997 | 1961 |
| Country | United States | United States |
| Employees | N/A | 1386 |
| Industry | Medical Specialities | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 568.3M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | MOV |
|---|---|---|
| Price | $15.45 | $27.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $18.33 | ★ $31.50 |
| AVG Volume (30 Days) | 165.9K | ★ 167.2K |
| Earning Date | 05-12-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | $1.92 |
| Revenue Next Year | $24.46 | $0.67 |
| P/E Ratio | ★ N/A | $25.52 |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $12.90 |
| 52 Week High | $18.97 | $27.38 |
| Indicator | NPCE | MOV |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 67.22 |
| Support Level | $15.25 | $22.95 |
| Resistance Level | $15.71 | N/A |
| Average True Range (ATR) | 0.67 | 0.71 |
| MACD | 0.22 | 0.27 |
| Stochastic Oscillator | 91.26 | 92.69 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.